Concepedia

Author

David I. Lichter

Emory University

Also Known As

D. Lichter, David I Lichter, David I. Lichter, David Lichter

22

Publications

373

Citations

4

H-Index

0

Concepts

All Affiliations

Emory UniversityJanssen (Belgium)Harvard UniversityMillennium Engineering and Integration (United States)Janssen (United States)
DI

About

David I. Lichter is an author at Emory University.

David I. Lichter

×

4

Publications

362

Citations

4

H-Index

YearCitations

Mutation of NRAS but not KRAS significantly reduces myeloma sensitivity to single-agent bortezomib therapy

George Mulligan, David I. Lichter, Alessandra Di Bacco,

Blood

2013

115

A Phase 1b Safety Study of SER-287, a Spore-Based Microbiome Therapeutic, for Active Mild to Moderate Ulcerative Colitis

Matthew R. Henn, Edward J. O’Brien, Liyang Diao,

Gastroenterology

2020

102

Antitumor effects of the investigational selective MEK inhibitor TAK733 against cutaneous and uveal melanoma cell lines

Erika von Euw, Mohammad Atefi, Narsis Attar,

Molecular Cancer

2012

74

Sequence analysis of β-subunit genes of the 20S proteasome in patients with relapsed multiple myeloma treated with bortezomib or dexamethasone

David I. Lichter, Hadi Danaee, Michael D. Pickard,

Blood

2012

71

Page 1